PL373090A1 - 9-alfa-podstawione estratrieny jako estrogeny o selektywnej aktywności - Google Patents

9-alfa-podstawione estratrieny jako estrogeny o selektywnej aktywności

Info

Publication number
PL373090A1
PL373090A1 PL03373090A PL37309003A PL373090A1 PL 373090 A1 PL373090 A1 PL 373090A1 PL 03373090 A PL03373090 A PL 03373090A PL 37309003 A PL37309003 A PL 37309003A PL 373090 A1 PL373090 A1 PL 373090A1
Authority
PL
Poland
Prior art keywords
alpha
selectively active
active estrogen
substituted estratrienes
estratrienes
Prior art date
Application number
PL03373090A
Other languages
English (en)
Other versions
PL209910B1 (pl
Inventor
Dirk Kosemund
Gerd Müller
Alexander Hillisch
Karl-Heinrich Fritzemeier
Peter Muhn
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL373090A1 publication Critical patent/PL373090A1/pl
Publication of PL209910B1 publication Critical patent/PL209910B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL373090A 2002-06-11 2003-06-11 9-alfa-podstawione pochodne estra -1,3,5 (10) -trienu, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie PL209910B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10226326A DE10226326A1 (de) 2002-06-11 2002-06-11 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene

Publications (2)

Publication Number Publication Date
PL373090A1 true PL373090A1 (pl) 2005-08-08
PL209910B1 PL209910B1 (pl) 2011-11-30

Family

ID=29723144

Family Applications (1)

Application Number Title Priority Date Filing Date
PL373090A PL209910B1 (pl) 2002-06-11 2003-06-11 9-alfa-podstawione pochodne estra -1,3,5 (10) -trienu, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie

Country Status (29)

Country Link
EP (1) EP1517914B1 (pl)
JP (1) JP4615998B2 (pl)
KR (1) KR101006612B1 (pl)
CN (1) CN1293090C (pl)
AR (1) AR040188A1 (pl)
AT (1) ATE303397T1 (pl)
AU (1) AU2003242683B9 (pl)
BR (1) BR0312140A (pl)
CA (1) CA2486495C (pl)
CR (1) CR10289A (pl)
CU (1) CU23414B7 (pl)
DE (2) DE10226326A1 (pl)
DK (1) DK1517914T3 (pl)
EA (1) EA008442B1 (pl)
EC (1) ECSP055530A (pl)
ES (1) ES2248770T3 (pl)
HK (1) HK1081203A1 (pl)
HR (1) HRP20050009B1 (pl)
IL (1) IL165321A (pl)
MX (1) MXPA04012491A (pl)
NO (1) NO329563B1 (pl)
PE (1) PE20040613A1 (pl)
PL (1) PL209910B1 (pl)
RS (1) RS50878B (pl)
TW (1) TWI286140B (pl)
UA (1) UA78062C2 (pl)
UY (1) UY27844A1 (pl)
WO (1) WO2003104253A2 (pl)
ZA (1) ZA200500217B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PT1689410E (pt) * 2003-11-26 2008-08-18 Bayer Schering Pharma Ag Prevenção e tratamento de doenças cardíacas hipertensivas pelos estrogénios selectivos 8beta-vinil-estra-1,3,5(10)-trieno-3,17beta-diol e 17beta-fluoro-9alfa-vinil-estra-1,3,5(10)-trieno-3,16alfa-diol
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
JP2012509286A (ja) * 2008-11-21 2012-04-19 バイエル ファーマ アクチエンゲゼルシャフト 薬物送達システム
EP3185881B1 (en) 2014-08-26 2022-03-09 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336432A1 (de) 1973-07-13 1975-01-30 Schering Ag 3.17.18-trihydroxy-1.3.5(10)-oestratriene
US6154158A (en) * 1998-06-30 2000-11-28 Qualcomm Incorporated Digital-to-analog converter D.C. offset correction comparing converter input and output signals
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
AU1855201A (en) * 1999-11-02 2001-05-14 Schering Aktiengesellschaft 18-nor-steroids as selectively active estrogens
JP3828423B2 (ja) * 2000-04-12 2006-10-04 シエーリング アクチエンゲゼルシャフト ８β−置換された１１β−ペンチル−及び１１β−ヘキシル−エストラ−１，３，５（１０）−トリエン誘導体類

Also Published As

Publication number Publication date
TW200407331A (en) 2004-05-16
CA2486495A1 (en) 2003-12-18
DE50301116D1 (de) 2005-10-06
HRP20050009B1 (hr) 2013-07-31
NO20050127L (no) 2005-03-11
KR20050009745A (ko) 2005-01-25
AR040188A1 (es) 2005-03-16
RS50878B (sr) 2010-08-31
WO2003104253A2 (de) 2003-12-18
ECSP055530A (es) 2005-03-10
IL165321A (en) 2009-08-03
AU2003242683B9 (en) 2009-08-27
HRP20050009A2 (en) 2005-04-30
EP1517914A2 (de) 2005-03-30
UA78062C2 (en) 2007-02-15
KR101006612B1 (ko) 2011-01-10
ES2248770T3 (es) 2006-03-16
NO329563B1 (no) 2010-11-15
EA008442B1 (ru) 2007-06-29
TWI286140B (en) 2007-09-01
BR0312140A (pt) 2005-04-05
UY27844A1 (es) 2003-12-31
CU23414B7 (es) 2009-09-08
CR10289A (es) 2008-11-26
AU2003242683A1 (en) 2003-12-22
EA200401544A1 (ru) 2005-06-30
NO20050127D0 (no) 2005-01-10
PE20040613A1 (es) 2004-12-01
WO2003104253A3 (de) 2004-09-16
DE10226326A1 (de) 2004-01-15
AU2003242683B2 (en) 2009-07-02
CN1659181A (zh) 2005-08-24
CA2486495C (en) 2011-04-19
ZA200500217B (en) 2006-03-29
HK1081203A1 (en) 2006-05-12
EP1517914B1 (de) 2005-08-31
CN1293090C (zh) 2007-01-03
DK1517914T3 (da) 2006-01-16
JP2005533053A (ja) 2005-11-04
JP4615998B2 (ja) 2011-01-19
PL209910B1 (pl) 2011-11-30
MXPA04012491A (es) 2005-06-08
RS107004A (en) 2006-10-27
ATE303397T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
ZA200602339B (en) HRT Formulations
IL175843A0 (en) Hrt formulations
AU2003266227A8 (en) Crossmember
ZA200507351B (en) Steroid spirolactonization
HK1081203A1 (en) 9-Alpha-substituted estratrienes as selectively active estrogen
PL370457A1 (pl) Nowe kortykosteroidy
EP1625143A4 (en) ÖSTRATRIENDERIVATE
GB2398992B (en) Underwear
SI1517914T1 (sl) 9-alfa-substituirani estratrieni kot selektivno ucinkoviti estrogeni
IL165321A0 (en) 9-alpha-substituted estratrienes as selectively active estrogen
IL173608A0 (en) 15-d-homosteroids having an androgenic effect
TW560398U (en) Improved structure for scissors
GB0312262D0 (en) An undergarment
GB2390533B (en) Undergarment
GB0203608D0 (en) Improved undergarment
GB0330045D0 (en) An envelope
AU2003246936A1 (en) Improved bib
ZA200609275B (en) D-homo-17-chloro-16(17)en steroids
ZA200602305B (en) Δ15-D-Homosteroids having an androgenic effect
CA94412S (en) Envelope
HU0200217V0 (en) Construction for newspaper
TW580978U (en) Improved structure for scissors
SI1539184T1 (sl) Rezim nadomestitve estrogena
AU153205S (en) Envelope
TW547388U (en) Improved structure for spoiler

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140611